Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010873
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Its products and solutions are used for the treatment of patients suffering from disorders or injuries in bones, joints and supporting soft tissues. The company offers its products to orthopaedic surgeons, neurosurgeons, oral surgeons, other specialists, dentists and hospitals. The company sells its products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Indiana, the US.

Zimmer Biomet Holdings Inc (ZBH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Zimmer Biomet Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zimmer Biotech Raises USD8.3 Million in Venture Financing 12
Private Equity 13
JANA Partners May Acquire Certain Stake in Zimmer Biomet 13
Partnerships 14
MiMedx Enters into Distribution Agreement with Zimmer 14
curasan Enters Into Distribution Agreement With Zimmer Dental 15
Licensing Agreements 16
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 16
Equity Offering 17
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 17
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 19
Debt Offering 20
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 20
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 21
Acquisition 22
Zimmer Acquires Biomet for USD14 Billion 22
Zimmer Acquires Dornoch Medical Systems 24
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 25
Zimmer Biomet Holdings Inc – Key Competitors 26
Zimmer Biomet Holdings Inc – Key Employees 27
Zimmer Biomet Holdings Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 35
Financial Announcements 35
Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results 35
Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 36
Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 37
Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 38
Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 39
Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 40
Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 41
Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 42
Apr 28, 2016: Zimmer Biomet Holdings Reports First Quarter 2016 Financial Results 43
Corporate Communications 44
Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 44
Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 45
Legal and Regulatory 46
Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 46
Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 47
Government and Public Interest 48
Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 48
Sep 22, 2016: Zimmer Biomet Contributes Additional $100,000 in Funding to the Orthopaedic Research and Education Foundation 49
Product News 50
Sep 08, 2016: Zimmer Biomet creates new jobs at Bridgend factory 50
Other Significant Developments 51
Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Zimmer Biomet Holdings Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Zimmer Biomet Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Zimmer Biotech Raises USD8.3 Million in Venture Financing 12
JANA Partners May Acquire Certain Stake in Zimmer Biomet 13
MiMedx Enters into Distribution Agreement with Zimmer 14
curasan Enters Into Distribution Agreement With Zimmer Dental 15
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 16
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 17
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 19
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 20
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 21
Zimmer Acquires Biomet for USD14 Billion 22
Zimmer Acquires Dornoch Medical Systems 24
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 25
Zimmer Biomet Holdings Inc, Key Competitors 26
Zimmer Biomet Holdings Inc, Key Employees 27
Zimmer Biomet Holdings Inc, Other Locations 29
Zimmer Biomet Holdings Inc, Subsidiaries 30

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kansas Electric Power Cooperative Inc:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Michael Kors Holdings Ltd:企業の戦略・SWOT・財務情報
    Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TPF SA:企業の戦略的SWOT分析
    TPF SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Electronic Control Security Inc.:企業の戦略・SWOT・財務情報
    Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SEGRO Plc:企業のM&A・事業提携・投資動向
    SEGRO Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEGRO Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務情報
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dawnbreaker, Inc.:企業の戦略・SWOT・財務情報
    Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company. It discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of n …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Guitar Center, Inc.:企業の戦略的SWOT分析
    Guitar Center, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Energizer Holdings, Inc. (ENR):企業の財務・戦略的SWOT分析
    Energizer Holdings, Inc. (ENR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Federal-Mogul Holdings LLC:企業の戦略的SWOT分析
    Federal-Mogul Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Macmahon Holdings Ltd:企業の戦略・SWOT・財務分析
    Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Jordan Trade Facilities Company PLC (JOTF):企業の財務・戦略的SWOT分析
    Jordan Trade Facilities Company PLC (JOTF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • OSANG Healthcare Co Ltd (036220):製品パイプライン分析
    Summary OSANG Healthcare Co Ltd (OSANG), formerly Infopia Co Ltd is a medical device company that designs, develops and distributes diagnostic biosensors for heart disease and cancers and remote diagnosing systems. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholester …
  • Cosmo Energy Holdings Co Ltd (5021):企業の財務・戦略的SWOT分析
    Cosmo Energy Holdings Co Ltd (5021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆